Read More Pharma Industry News OcuMension secures Alcon eye drop rights with 16.7% stake, marking major strategic shift OcuMension Therapeutics has struck a landmark deal with Alcon Inc., acquiring commercialization rights for a portfolio of eye… byPallavi MadhirajuAugust 13, 2024